Alembic Pharmaceuticals is trading -0.30% lower at Rs 937.80 as compared to its last closing price. Alembic Pharmaceuticals has been trading in the price range of 946.55 & 923.15. Alembic Pharmaceuticals has given -12.34% in this year & -6.45% in the last 5 days. Alembic Pharmaceuticals has TTM P/E ratio 31.32 as compared to the sector P/E of 22.54.There are 11 analysts who have initiated coverage on Alembic Pharmaceuticals. There are 3 analysts who have given it a strong buy rating & 2 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 156.87 Crores in its last quarter.Listed peers of Alembic Pharmaceuticals include Syngene International (0.65%), Eris Lifesciences (-0.25%), Alembic Pharmaceuticals (-0.30%).The Mutual Fund holding in Alembic Pharmaceuticals was at 9.20% in 31 Mar 2025. The MF holding has increased from the last quarter. The FII holding in Alembic Pharmaceuticals was at 3.94% in 31 Mar 2025. The FII holding has decreased from the last quarter.
Updated on Jun 23, 2025, 10:45 AM UTC
|
|
|
|
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
---|---|---|---|---|---|---|---|---|
Syngene International | Bearish | 636.05 | 0.65 | 25,698.67 | 53.76 | 5.36 | 0.20 | 8.65 |
Eris Lifesciences | Neutral | 1,620.00 | -0.25 | 22,129.64 | 63.02 | 7.76 | 0.45 | 62.42 |
Alembic Pharmaceuticals | Neutral | 937.80 | -0.30 | 18,453.49 | 32.22 | 3.54 | 1.18 | 0.90 |
Jubilant Pharmova | Neutral | 1,123.15 | 1.31 | 17,924.66 | 33.03 | 2.81 | 0.45 | 38.19 |
Natco Pharma | Bearish | 867.95 | -0.84 | 15,545.84 | 8.31 | 2.06 | 0.69 | 0.06 |
Meeting Date | Purpose |
---|---|
2025-05-06 | Audited Results & Final Dividend |
2025-02-03 | Quarterly Results & Others |
2024-11-07 | Quarterly Results |
2024-08-08 | Quarterly Results |
2024-05-09 | Audited Results & Final Dividend |
Alembic Pharmaceuticals is trading at 937.80 as on Mon Jun 23 2025 09:59:39. This is -0.30% lower as compared to its previous closing price of 940.65.
The market capitalization of Alembic Pharmaceuticals is 18453.49 Cr as on Mon Jun 23 2025 09:59:39.
The average broker rating on Alembic Pharmaceuticals is Buy. The breakup of analyst rating is given below -
The 52 wk high for Alembic Pharmaceuticals is 1296.15 whereas the 52 wk low is 725.60
Alembic Pharmaceuticals can be analyzed on the following key metrics -
Alembic Pharmaceuticals reported a net profit of 583.42 Cr in 2025.
The Mutual Fund Shareholding was 9.20% at the end of 31 Mar 2025.